Hypermethylation and decreased expression of TMEM240 are potential early-onset biomarkers for colorectal cancer detection, poor prognosis, and early recurrence prediction

BACKGROUND: Gene silencing by aberrant DNA methylation of promoter regions remains the most dominant phenomenon occurring during tumorigenesis. Improving the early diagnosis, prognosis, and recurrence prediction of colorectal cancer using noninvasive aberrant DNA methylation biomarkers has encouragi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Shih-Ching, Liew, Phui-Ly, Ansar, Muhamad, Lin, Shih-Yun, Wang, Sheng-Chao, Hung, Chin-Sheng, Chen, Jian-Yu, Jain, Shikha, Lin, Ruo-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218647/
https://www.ncbi.nlm.nih.gov/pubmed/32398064
http://dx.doi.org/10.1186/s13148-020-00855-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218647/
https://www.ncbi.nlm.nih.gov/pubmed/32398064
http://dx.doi.org/10.1186/s13148-020-00855-z

Ejemplares similares